National Health (Price and Special Patient Contribution) Amendment Determination 2016 (No. 3) (PB 30 of 2016) (Cth)

PB 30 of 2016

National Health (Price and Special Patient Contribution) Amendment Determination 2016 (No. 3)

National Health Act 1953

I, PENNY SHAKESPEARE, First Assistant Secretary, Pharmaceutical Benefits Division, Department of Health, delegate of the Minister for Health, make this Determination under section 85B of the National Health Act 1953.

Dated 29 April 2016

PENNY SHAKESPEARE
First Assistant Secretary
Pharmaceutical Benefits Division
Department of Health

1 Name of Instrument

(1) This Instrument is the National Health (Price and Special Patient Contribution) Amendment Determination 2016 (No. 3).
(2) This Instrument may also be cited as PB 30 of 2016.

2 Commencement

This Instrument commences on 1 May 2016.

3 Amendment of the National Health (Price and Special Patient Contribution) Determination 2010 (PB 109 of 2010)
Schedule 1 amends the National Health (Price and Special Patient Contribution) Determination 2010 (PB 109 of 2010).

Schedule 1 Amendments

[1] Schedule 1, entry for Amlodipine in the form Tablet 5 mg (as besylate)

(a) omit from the column headed “Determined Price”: 1.21 substitute: 1.00
(b) omit from the column headed “Claimed Price”: 8.29 substitute: 6.85

[2] Schedule 1, entry for Amlodipine in the form Tablet 10 mg (as besylate)

(a) omit from the column headed “Determined Price”: 2.12 substitute: 1.76
(b) omit from the column headed “Claimed Price”: 11.25 substitute: 9.34

[3] Schedule 1, entry for Bisoprolol in the form Tablet containing bisoprolol fumarate 2.5 mg

(a) omit from the column headed “Determined Price”: 11.96 substitute: 10.64
(b) omit from the column headed “Claimed Price”: 14.35 substitute: 12.77

[4] Schedule 1, entry for Bisoprolol in the form Tablet containing bisoprolol fumarate 5 mg

(a) omit from the column headed “Determined Price”: 14.94 substitute: 13.30
(b) omit from the column headed “Claimed Price”: 17.33 substitute: 15.43

[5] Schedule 1, entry for Bisoprolol in the form Tablet containing bisoprolol fumarate 10 mg

(a) omit from the column headed “Determined Price”: 18.68 substitute: 16.63
(b) omit from the column headed “Claimed Price”: 21.07 substitute: 18.76

[6] Schedule 1, entry for Candesartan in the form Tablet containing candesartan cilexetil 4 mg

(a) omit from the column headed “Determined Price”: 0.88 substitute: 0.74
(b) omit from the column headed “Claimed Price”: 2.74 substitute: 2.30

[7] Schedule 1, entry for Candesartan in the form Tablet containing candesartan cilexetil 8 mg

(a) omit from the column headed “Determined Price”: 2.62 substitute: 2.20
(b) omit from the column headed “Claimed Price”: 4.48 substitute: 3.76

[8] Schedule 1, entry for Candesartan in the form Tablet containing candesartan cilexetil 16 mg

(a) omit from the column headed “Determined Price”: 7.85 substitute: 6.58
(b) omit from the column headed “Claimed Price”: 9.71 substitute: 8.14

[9] Schedule 1, entry for Candesartan in the form Tablet containing candesartan cilexetil 32 mg

(a) omit from the column headed “Determined Price”: 9.49 substitute: 7.95
(b) omit from the column headed “Claimed Price”: 11.35 substitute: 9.51

Schedule 1, entry for Candesartan with Hydrochlorothiazide in the form Tablet containing candesartan cilexetil 16 mg with hydrochlorothiazide 12.5 mg
(a) omit from the column headed “Determined Price”: 8.96 substitute: 8.09
(b) omit from the column headed “Claimed Price”: 10.82 substitute: 9.77
Schedule 1, entry for Candesartan with Hydrochlorothiazide in the form Tablet containing candesartan cilexetil 32 mg with hydrochlorothiazide 12.5 mg
(a) omit from the column headed “Determined Price”: 10.66 substitute: 9.46
(b) omit from the column headed “Claimed Price”: 12.52 substitute: 11.11
Schedule 1, entry for Candesartan with Hydrochlorothiazide in the form Tablet containing candesartan cilexetil 32 mg with hydrochlorothiazide 25 mg
(a) omit from the column headed “Determined Price”: 11.47 substitute: 10.97
(b) omit from the column headed “Claimed Price”: 13.33 substitute: 12.75
Schedule 1, entry for Carmellose in each of the forms: Eye drops containing carmellose sodium 5 mg per mL, single dose units 0.4 mL, 30; and Eye drops containing carmellose sodium 10 mg per mL, single dose units 0.4 mL, 30
(a) omit from the column headed “Determined Price”: 6.71 substitute: 6.37
(b) omit from the column headed “Claimed Price”: 7.99 substitute: 7.59
Schedule 1, entry for Clindamycin
(a) omit from the column headed “Determined Price”: 9.06 substitute: 7.87
(b) omit from the column headed “Claimed Price”: 16.66 substitute: 14.47
Schedule 1, entry for Doxepin in the form Capsule 10 mg (as hydrochloride)
(a) omit from the column headed “Determined Price”: 2.83 substitute: 2.69
(b) omit from the column headed “Claimed Price”: 8.28 substitute: 7.87
Schedule 1, entry for Doxepin in the form Capsule 25 mg (as hydrochloride)
(a) omit from the column headed “Determined Price”: 2.94 substitute: 2.79
(b) omit from the column headed “Claimed Price”: 8.27 substitute: 7.86
Schedule 1, entry for Escitalopram in the form Tablet 10 mg (as oxalate)
(a) omit from the column headed “Determined Price”: 3.40 substitute: 2.73
(b) omit from the column headed “Claimed Price”: 9.95 substitute: 7.99
Schedule 1, entry for Escitalopram in the form Tablet 20 mg (as oxalate)
(a) omit from the column headed “Determined Price”: 3.43 substitute: 2.75
(b) omit from the column headed “Claimed Price”: 10.30 substitute: 8.26
Schedule 1, entry for Exemestane
(a) omit from the column headed “Determined Price”: 84.64 substitute: 71.67
(b) omit from the column headed “Claimed Price”: 86.50 substitute: 73.25
Schedule 1, entry for Fluoxetine in each of the forms: Capsule 20 mg (as hydrochloride); and Tablet, dispersible, 20 mg (as hydrochloride)
(a) omit from the column headed “Determined Price”: 4.52 substitute: 3.98
(b) omit from the column headed “Claimed Price”: 5.96 substitute: 5.25
Schedule 1, entry for Labetalol in the form Tablet containing labetalol hydrochloride 100 mg
(a) omit from the column headed “Determined Price”: 9.61 substitute: 7.79
(b) omit from the column headed “Claimed Price”: 12.52 substitute: 10.15
Schedule 1, entry for Labetalol in the form Tablet containing labetalol hydrochloride 200 mg
(a) omit from the column headed “Determined Price”: 14.25 substitute: 12.32
(b) omit from the column headed “Claimed Price”: 17.17 substitute: 14.85
Schedule 1, entry for Lamotrigine in the form Tablet 25 mg
(a) omit from the column headed “Determined Price”: 8.02 substitute: 6.38
(b) omit from the column headed “Claimed Price”: 10.35 substitute: 8.23
Schedule 1, entry for Lamotrigine in the form Tablet 50 mg
(a) omit from the column headed “Determined Price”: 13.38 substitute: 10.64
(b) omit from the column headed “Claimed Price”: 15.45 substitute: 12.29
Schedule 1, entry for Lamotrigine in the form Tablet 100 mg
(a) omit from the column headed “Determined Price”: 22.28 substitute: 17.71
(b) omit from the column headed “Claimed Price”: 24.44 substitute: 19.43
Schedule 1, entry for Lamotrigine in the form Tablet 200 mg
(a) omit from the column headed “Determined Price”: 37.44 substitute: 29.77
(b) omit from the column headed “Claimed Price”: 39.60 substitute: 31.49
Schedule 1, entry for Lansoprazole in the form Tablet 15 mg (orally disintegrating)
(a) omit from the column headed “Determined Price”: 5.40 substitute: 4.57
(b) omit from the column headed “Claimed Price”: 11.88 substitute: 10.05
Schedule 1, entry for Lansoprazole in the form Tablet 30 mg (orally disintegrating)
(a) omit from the column headed “Determined Price”: 9.70 substitute: 8.22
(b) omit from the column headed “Claimed Price”: 16.17 substitute: 13.70
Schedule 1, entry for Lisinopril in the form Tablet 5 mg
(a) omit from the column headed “Determined Price”: 2.62 substitute: 2.34
(b) omit from the column headed “Claimed Price”: 5.68 substitute: 5.07
Schedule 1, entry for Lisinopril in the form Tablet 10 mg [Brand: Prinivril 10]
(a) omit from the column headed “Determined Price”: 3.92 substitute: 3.50
(b) omit from the column headed “Claimed Price”: 6.51 substitute: 5.81
Schedule 1, entry for Lisinopril in the form Tablet 10 mg [Brand: Zestril]
(a) omit from the column headed “Determined Price”: 3.92 substitute: 3.50
(b) omit from the column headed “Claimed Price”: 6.97 substitute: 6.22
Schedule 1, entry for Lisinopril in the form Tablet 20 mg [Brand: Prinivril 20]
(a) omit from the column headed “Determined Price”: 4.94 substitute: 4.41
(b) omit from the column headed “Claimed Price”: 7.53 substitute: 6.72
Schedule 1, entry for Lisinopril in the form Tablet 20 mg [Brand: Zestril]
(a) omit from the column headed “Determined Price”: 4.94 substitute: 4.41
(b) omit from the column headed “Claimed Price”: 8.02 substitute: 7.16
Schedule 1, entry for Meloxicam in the form Capsule 7.5 mg
(a) omit from the column headed “Determined Price”: 3.65 substitute: 3.23
(b) omit from the column headed “Claimed Price”: 5.98 substitute: 5.29
Schedule 1, entry for Meloxicam in the form Capsule 15 mg
(a) omit from the column headed “Determined Price”: 5.33 substitute: 4.71
(b) omit from the column headed “Claimed Price”: 7.65 substitute: 6.76
Schedule 1, entry for Meloxicam in the form Tablet 7.5 mg
(a) omit from the column headed “Determined Price”: 3.65 substitute: 3.23
(b) omit from the column headed “Claimed Price”: 5.98 substitute: 5.29
Schedule 1, entry for Meloxicam in the form Tablet 15 mg
(a) omit from the column headed “Determined Price”: 5.33 substitute: 4.71
(b) omit from the column headed “Claimed Price”: 7.65 substitute: 6.76
Schedule 1, entry for Metoclopramide
(a) omit from the column headed “Determined Price”: 1.21 substitute: 1.05
(b) omit from the column headed “Claimed Price”: 3.26 substitute: 2.83
Schedule 1, entry for Mirtazapine in the form Tablet 15 mg (orally disintegrating)
(a) omit from the column headed “Determined Price”: 5.49 substitute: 4.52
(b) omit from the column headed “Claimed Price”: 6.60 substitute: 5.43
Schedule 1, entry for Mirtazapine in the form Tablet 30 mg
(a) omit from the column headed “Determined Price”: 4.78 substitute: 3.93
(b) omit from the column headed “Claimed Price”: 8.04 substitute: 6.61
Schedule 1, entry for Mirtazapine in the form Tablet 30 mg (orally disintegrating)
(a) omit from the column headed “Determined Price”: 7.32 substitute: 6.02
(b) omit from the column headed “Claimed Price”: 8.44 substitute: 6.94
Schedule 1, entry for Mirtazapine in the form Tablet 45 mg
(a) omit from the column headed “Determined Price”: 7.96 substitute: 6.55
(b) omit from the column headed “Claimed Price”: 11.22 substitute: 9.23
Schedule 1, entry for Mirtazapine in the form Tablet 45 mg (orally disintegrating)
(a) omit from the column headed “Determined Price”: 11.03 substitute: 9.07
(b) omit from the column headed “Claimed Price”: 12.15 substitute: 9.99
Schedule 1, entry for Mometasone in the form Cream containing mometasone furoate 1 mg per g, 15 g
(a) omit from the column headed “Determined Price”: 4.52 substitute: 3.85
(b) omit from the column headed “Claimed Price”: 7.00 substitute: 5.96
Schedule 1, entry for Mometasone in the form Lotion containing mometasone furoate 1 mg per g, 30 mL
(a) omit from the column headed “Determined Price”: 7.13 substitute: 6.07
(b) omit from the column headed “Claimed Price”: 9.61 substitute: 8.18
Schedule 1, entry for Mometasone in the form Ointment containing mometasone furoate 1 mg per g, 15 g
(a) omit from the column headed “Determined Price”: 4.52 substitute: 3.85
(b) omit from the column headed “Claimed Price”: 7.00 substitute: 5.96
Schedule 1, entry for Naratriptan
(a) omit from the column headed “Determined Price”: 7.88 substitute: 7.49
(b) omit from the column headed “Claimed Price”: 9.00 substitute: 8.55
Schedule 1, entry for Omeprazole
(a) omit from the column headed “Determined Price”: 5.48 substitute: 4.74
(b) omit from the column headed “Claimed Price”: 8.32 substitute: 7.20
Schedule 1, entry for Perindopril [Brands: Coversyl 2.5mg; PREXUM 2.5]
(a) omit from the column headed “Determined Price”: 2.33 substitute: 2.05
(b) omit from the column headed “Claimed Price”: 4.15 substitute: 3.65
Schedule 1, entry for Pravastatin in the form Tablet containing pravastatin sodium 10 mg
(a) omit from the column headed “Determined Price”: 2.00 substitute: 1.72
(b) omit from the column headed “Claimed Price”: 3.12 substitute: 2.68
Schedule 1, entry for Pravastatin in the form Tablet containing pravastatin sodium 20 mg
(a) omit from the column headed “Determined Price”: 3.17 substitute: 2.73
(b) omit from the column headed “Claimed Price”: 4.28 substitute: 3.69
Schedule 1, entry for Pravastatin in the form Tablet containing pravastatin sodium 40 mg
(a) omit from the column headed “Determined Price”: 4.93 substitute: 4.24
(b) omit from the column headed “Claimed Price”: 6.11 substitute: 5.25
Schedule 1, entry for Pravastatin in the form Tablet containing pravastatin sodium 80 mg
(a) omit from the column headed “Determined Price”: 7.58 substitute: 6.52
(b) omit from the column headed “Claimed Price”: 8.76 substitute: 7.54
Schedule 1, entry for Ranitidine in each of the forms: Tablet 150 mg (as hydrochloride); and Tablet 300 mg (as hydrochloride)
(a) omit from the column headed “Determined Price”: 4.33 substitute: 3.85
(b) omit from the column headed “Claimed Price”: 5.47 substitute: 4.86
Schedule 1, entry for Sertraline in each of the forms: Tablet 50 mg (as hydrochloride); and Tablet 100 mg (as hydrochloride)
(a) omit from the column headed “Determined Price”: 2.26 substitute: 1.86
(b) omit from the column headed “Claimed Price”: 8.22 substitute: 6.77
Schedule 1, entry for Telmisartan in the form Tablet 40 mg
(a) omit from the column headed “Determined Price”: 3.75 substitute: 3.34
(b) omit from the column headed “Claimed Price”: 5.25 substitute: 4.68
Schedule 1, entry for Telmisartan in the form Tablet 80 mg
(a) omit from the column headed “Determined Price”: 10.86 substitute: 9.67
(b) omit from the column headed “Claimed Price”: 12.36 substitute: 11.01
Schedule 1, entry for Telmisartan with amlodipine in the form Tablet 40 mg-5 mg (as besylate)
(a) omit from the column headed “Determined Price”: 6.84 substitute: 4.27
(b) omit from the column headed “Claimed Price”: 8.34 substitute: 5.21
Schedule 1, entry for Telmisartan with amlodipine in the form Tablet 40 mg-10 mg (as besylate)
(a) omit from the column headed “Determined Price”: 8.01 substitute: 4.98
(b) omit from the column headed “Claimed Price”: 9.51 substitute: 5.91
Schedule 1, entry for Telmisartan with amlodipine in the form Tablet 80 mg-5 mg (as besylate)
(a) omit from the column headed “Determined Price”: 16.85 substitute: 10.60
(b) omit from the column headed “Claimed Price”: 18.35 substitute: 11.54
Schedule 1, entry for Telmisartan with amlodipine in the form Tablet 80 mg-10 mg (as besylate)
(a) omit from the column headed “Determined Price”: 18.02 substitute: 11.31
(b) omit from the column headed “Claimed Price”: 19.52 substitute: 12.25
Schedule 1, entry for Telmisartan with hydrochlorothiazide in the form Tablet 40 mg-12.5 mg
(a) omit from the column headed “Determined Price”: 5.25 substitute: 4.45
(b) omit from the column headed “Claimed Price”: 6.75 substitute: 5.72
Schedule 1, entry for Telmisartan with hydrochlorothiazide in the form Tablet 80 mg-12.5 mg
(a) omit from the column headed “Determined Price”: 13.12 substitute: 11.08
(b) omit from the column headed “Claimed Price”: 14.62 substitute: 12.35
Schedule 1, entry for Telmisartan with hydrochlorothiazide in the form Tablet 80 mg-25 mg
(a) omit from the column headed “Determined Price”: 14.23 substitute: 12.07
(b) omit from the column headed “Claimed Price”: 15.73 substitute: 13.34

Schedule 1, entry for Zolmitriptan
(a) omit from the column headed “Determined Price”: 7.85 substitute: 7.04
(b) omit from the column headed “Claimed Price”: 9.13 substitute: 8.19